Albert Einstein Cancer Center

Phase II - Definition

Phase II Studies gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition). For example, participants receiving the drug may be compared with similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.
SEARCH 

Message From the Director

I. David Goldman, M.D.

Since the start of the 20th century, scientists have sought ways of harnessing the immune system to attack cancer cells. The challenge has been enormous. The immune system is designed to destroy foreign ... 

read more 

 
 

Contact us

Albert Einstein Cancer Center
1300 Morris Park Avenue
Bronx, New York 10461
Telephone: 718.430.2302
aecc@einstein.yu.edu  

Twitter image  LinkedIn image 

 

Calendar of Events

Click here to log in